copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastiske midler - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
vydura
pfizer europe ma eeig - rimegepant - migræneforstyrrelser - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
rayvow
eli lilly nederland b.v. - lasmiditan succinate - migræneforstyrrelser - analgetika - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.
cefa-cure vet. 200 mg tabletter
intervet international b.v. - cefadroxilmonohydrat - tabletter - 200 mg
cefa-cure vet. 1000 mg tabletter
intervet international b.v. - cefadroxilmonohydrat - tabletter - 1000 mg
cefa-cure vet. 50 mg tabletter
intervet international b.v. - cefadroxilmonohydrat - tabletter - 50 mg
milnocor 1 mg/ml injektions-/infusionsvæske, opløsning
macure pharma aps - milrinon - injektions-/infusionsvæske, opløsning - 1 mg/ml
andatin 500+500 mg pulver til infusionsvæske, opløsning
macure pharma aps - cilastatinnatrium, imipenem monohydrat - pulver til infusionsvæske, opløsning - 500+500 mg
xilmac 1000+200 mg pulver til injektions-/infusionsvæske, opløsning
macure pharma aps - amoxicillinnatrium, kaliumclavulanat - pulver til injektions-/infusionsvæske, opløsning - 1000+200 mg
veramacor 2,5 mg/ml injektions-/infusionsvæske, opløsning
macure pharma aps - verapamilhydrochlorid - injektions-/infusionsvæske, opløsning - 2,5 mg/ml